MD
Occupied territories Halal Trading Room controversy review flags companies domiciled in Israel under Occupied territories. as of 2026-09-11.
A public record of federal contracting, not a Sharia ruling and not our assessment of this company. It sits beside the verdict above and changes nothing about it.
Methodology breakdown computing — it will appear here on its own.
MediWound Ltd. (MDWD) is currently considered not halal (non-compliant), per In-house ratio engine (last assessed 2026-08-28). See the full ratio breakdown and business-activity screen below for the reasoning.
⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.
Computing the full ratio and business-activity breakdown for MDWD — this runs off the critical path so the page paints first. It will appear here on its own.
Computed from published company financials, balance sheet as of 2025-12-31. MDWD files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.
Business activity: cleared (no excluded categories detected)
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.00% | 30.00% | Pass |
| Interest-bearing investments | 30.97% | 30.00% | Fail |
| Non-permissible income | 0.00% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.00% | 33.00% | Pass |
| Interest-bearing investments | 61.61% | 33.00% | Fail |
| Non-liquid assets | 38.39% | at least 20.00% | Pass |
| Non-permissible income | 0.00% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.00% | 33.33% | Pass |
| Cash + interest-bearing securities | 61.61% | 33.33% | Fail |
| Non-permissible income | 0.00% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.00% | 33.33% | Pass |
| Cash + interest-bearing securities | 61.61% | 33.33% | Fail |
| Non-permissible income | 0.00% | 5.00% | Pass |
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.00% | 33.00% | Pass |
| Cash + interest-bearing securities | 28.10% | 33.00% | Pass |
| Non-permissible income | 0.00% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.00% | 33.00% | Pass |
| Cash + interest-bearing securities | 32.08% | 49.00% | Pass |
| Non-permissible income | 0.00% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.00% | 33.33% | Pass |
| Cash + interest-bearing securities | 32.08% | 33.33% | Pass |
| Non-permissible income | 0.00% | 5.00% | Pass |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 54.20 | NEUTRAL |
| Stochastic %K (14) | 76.77 | NEUTRAL |
| CCI (20) | 113.75 | SELL |
| Williams %R (14) | -23.23 | NEUTRAL |
| MACD (12,26,9) | 0.14 | BUY |
| ROC (10) | 3.55 | BUY |
| Momentum (10) | 0.47 | BUY |
| EMA (10) | 13.41 | BUY |
| SMA (10) | 13.21 | BUY |
| EMA (20) | 13.41 | BUY |
| SMA (20) | 13.23 | BUY |
| EMA (30) | 13.53 | BUY |
| SMA (30) | 13.51 | BUY |
| EMA (50) | 13.84 | SELL |
| SMA (50) | 13.90 | SELL |
| EMA (100) | 14.59 | SELL |
| SMA (100) | 14.70 | SELL |
| EMA (200) | 15.86 | SELL |
| SMA (200) | 16.17 | SELL |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Biotechnology
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Background via Yahoo Finance — informational, not part of the verdict.
Weak — low conviction, small size or skip
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BULLISH | 43 |
| ⏰ 4H | NEUTRAL | 23 |
| 🕐 1H | BULLISH | 95 |
| ⏱ 15-Min | RANGING | 130 |
| ⏲ 5-Min | BULLISH | 234 |
Peer movement computing — it will appear here on its own.
NEUTRAL 0 buys · 0 sells
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.